Related Experiment Video
Updated: Aug 22, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
[Severe epistaxis secondary to ticlopidine. Report of 3 cases]
V Pino Rivero1, M Marcos García, G Trinidad Ruíz
1Complejo Hospitalario Infanta Cristina, Badajoz. vicentepinorivero@terra.com
Abstract:
Ticlopidine (Ticlid@) is a platelet aggregation inhibitor that can produce bleeding or severe hemorrhage as a side-effect. The cases of three patients on previous treatment with that drug that required admission in our hospital because of recurrent epistaxis are reported. We have analysed their personal antecedents, complementary explorations, type of nasal packing used, clinical evolution and stay.
Related Concept Videos
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Tonsillitis II: Management
Transient Ischemic Attack l: Introduction
Venous Thrombosis III: Interprofessional Care